Portfolio company
Phitech
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops an artificial intelligence platform for multi-omics diagnostic decision support, serving hospitals, diagnostic laboratories and biopharmaceutical organisations.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Omica
This company develops artificial intelligence software to screen pathology slides for cancer biomarkers, serving hospital laboratories and biopharmaceutical partners to improve patient therapy selection.
Multiomic Health
This company develops an artificial intelligence platform for discovering precision medicines and biomarkers for patients with metabolic syndrome-related chronic diseases.
OMNIA-X
This company develops a health intelligence platform that integrates medical, biometric and behavioural data to provide personalised psychophysical health analysis for individuals.
Viseur AI
This company develops an artificial intelligence platform for medical imaging and digital pathology workflows to assist healthcare professionals in hospitals and diagnostic laboratories.
Preview Health
This company develops an artificial intelligence molecular profiling platform to help pharmaceutical companies and clinicians detect diseases and evaluate drug responses through biological samples.
Oncoradiomics
This deep-tech firm develops AI-powered image analysis software for pharmaceutical companies and clinicians to improve cancer diagnostics and treatment evaluation through quantitative imaging data.
AI Pathology
This company develops artificial intelligence software for cancer diagnosis and digital pathology image analysis to support pathologists and laboratories.
Panakeia
The company develops artificial intelligence software to provide rapid molecular cancer biomarker analysis from tissue images for hospitals and pharmaceutical research organisations.
